Caveolin-1 as a Novel Indicator of Wound-Healing Capacity in Aged Human Corneal Epithelium by Rhim, Ji Heon et al.
INTRODUCTION
Aged organisms have been suggested
to have the inefficient and slow wound-
healing capacity (1–4). The molecular
mechanisms of this age-dependent
delay in wound healing have not been
delineated. Endogenously produced
peptide growth factors such as epider-
mal growth factor (EGF), transforming
growth factor α (TGF-α) and platelet-
derived growth factor (PDGF) play key
roles in the natural wound-healing pro-
cess (1,2,5). A reduced mitogenic re-
sponse to growth  factors in aged cells
surrounding wounds may be responsi-
ble for the age-dependent, diminished
capacity for wound healing (1,2). The
molecular mechanism for reduced mito-
genic responses in aged cells varies
 depending on the respective growth
 factor (6,7).
Caveolin is a principal structural com-
ponent of caveolae membranes (8). Three
mammalian caveolin genes (caveolin-1, -2
and -3) have been identified and charac-
terized (9). Caveolin plays an important
role in growth-factor–induced cellular
signal transduction by interacting with
various signaling proteins, such as epi-
dermal growth factor receptor (EGFR),
G-proteins, Src-like kinases, Ha-Ras, pro-
tein kinase C, endothelial nitric-oxide
synthase and integrins (10–14). We previ-
ously observed that caveolin-1 levels in-
crease with aging (15), and caveolin-1 re-
duction by use of antisense oligonu-
cleotides or small-interfering RNA recov-
ers EGF response in senescent cells.
Because EGF receptor levels on the cell
surface do not change during aging, we
have suggested that accumulation of ex-
cess caveolin-1 protein might be respon-
sible for age-dependent decreases in EGF
response and morphological changes in
vitro (16,17).
The far-near ultraviolet radiation
(193-nm wavelength) generated by an
argon-fluoride excimer laser has been
used to ablate the cornea and reshape
its curvature to correct refractive errors,
such as myopia, astigmatism and hyper-
opia (18,19). This surgery, also called
laser epithelial keratomileusis (LASEK),
is more commonly performed in elderly
individuals who need refractive correc-
tion to improve vision and quality of
life. Postoperative care for the elderly
requires special concern for wound-
healing time and efficiency. Because
aging likely leads to delays in wound
healing, we compared the status of
corneal epithelia and wound-healing
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times from young and elderly patients
after LASEK. To test the possibility that
caveolin-1 might be involved in regulat-
ing wound healing after LASEK, we
compared expression of caveolin-1 with
expression of other age-related proteins,
such as p53 and p21waf1/cip1 (p21) in the
corneal epithelia from young and el-
derly patients.
MATERIALS AND METHODS
Human Corneal Cell Isolation and
Primary Culture
Human corneal epithelial cells were
isolated from tissue explants from do-
nated human corneas and cultivated as
described (20). Primary human corneal
epithelial (PHCEp) cells were maintained
in medium (Epilife; Cascade Biologics,
Portland, OR, USA) containing 0.06
mol/L CaCl2, and human corneal growth
supplement (Cascade Biologics). Cells
were maintained in a humidified atmos-
phere with 5% CO2 at 37°C, subcultured
with 0.25% trypsin-EDTA every 3 to 4 d
and used for experiments.
LASEK and Clinical Observations
This study involved 60 patients (120
eyes), with myopia range –3.00 to –5.00
diopters of spherical equivalent refrac-
tive power, who had undergone LASEK
for refractory correction during the pe-
riod from February 2005 to January 2008.
The Yong-San Hospital Institutional Re-
view Board (IRB) at the Chung-Ang Uni-
versity in Korea approved the surgery
(IRB# 2008-003-01). Before LASEK all
patients were examined carefully by an
ophthalmologist to determine the state
of the cornea. Exclusion criteria included
history of glaucoma or corneal disease,
previous corneal or intraocular surgery
and ocular inflammation. Patients were
divided into three groups according to
age: young group, age between 20 and
29 years; middle-aged group, between
40 and 49 years; and elderly group,
older than 50 years. The mean ages were
21.7 ± 2.0 years for the young group,
43.9 ± 2.9 years for the middle-aged
group, and 61.6 ± 4.3 years for the el-
derly group. Demographic information
can be found in Table 1.
All procedures were performed by one
surgeon according to the tenets of the
Helsinki Declaration. Written informed
consent was obtained from all patients.
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Table 1. Subject characteristics and corneal epithelial wound-healing times after LASEK.a
Wound-healing Wound-healing Wound-healing
time, h time, h time, h
Case no. Sex Age, years OD OS Case no. Sex Age, years OD OS Case no. Sex Age, years OD OS
Y1 F 20 48 48 M1 F 40 48 72 E1 F 54 72 96
Y2 M 20 48 48 M2 F 40 72 72 E2 M 56 72 96
Y3 M 20 48 48 M3 F 41 72 48 E3 M 56 96 72
Y4 M 20 48 72 M4 M 41 72 72 E4 M 57 72 120
Y5 F 20 72 48 M5 F 41 72 48 E5 F 58 96 72
Y6 F 20 48 72 M6 F 42 72 72 E6 M 59 72 72
Y7 F 20 48 48 M7 F 42 72 48 E7 M 60 96 120
Y8 F 20 48 48 M8 F 42 72 48 E8 F 60 96 120
Y9 F 20 48 48 M9 F 42 72 72 E9 F 60 96 96
Y10 M 21 48 48 M10 F 43 72 72 E10 F 60 120 96
Y11 F 21 48 48 M11 F 44 72 72 E11 F 61 96 72
Y12 F 21 48 48 M12 M 45 72 72 E12 F 62 120 96
Y13 F 22 48 48 M13 M 45 72 72 E13 M 63 96 120
Y14 F 22 48 48 M14 F 45 96 72 E14 F 63 120 96
Y15 M 23 72 48 M15 F 45 72 72 E15 F 65 120 120
Y16 M 23 48 48 M16 F 47 72 96 E16 F 65 96 120
Y17 M 24 48 48 M17 M 47 48 72 E17 F 65 120 120
Y18 M 24 72 72 M18 F 48 72 96 E18 F 68 96 120
Y19 F 25 48 48 M19 M 49 96 72 E19 F 69 96 120
Y20 F 27 72 48 M20 M 49 72 96 E20 M 70 96 96
Mean ± SD 21.7 ± 2.0 52.2 ± 9.2 Mean ± SD 43.9 ± 2.9 71.4 ± 12.7 Mean ± SD 61.6 ± 4.5 99.6 ± 17.7
aOD, right eye; OS, left eye.
Figure 1. Comparison of corneal wound-
healing times among young, middle-aged
and elderly groups. Corneal wound-heal-
ing times were measured in the young (40
eyes, 20 patients), middle-aged (40 eyes,
20 patients) and elderly groups (40 eyes,
20 patients). Bar graphs show the mean
wound-healing times in each age group.
There was a statistically significant differ-
ence between the young and middle-
aged or elderly group (***P < 0.001).
Before surgery, we excluded patients with
corneal lesion or erosion. To minimize the
influence of tear factors, we also excluded
patients with a tear breakup time (TBUT)
of less than 10 s (21). After application of
proparacaine hydrochloride 0.5% eye-
drops (Alcaine®; Alcon, Puurs, Belgium)
as topical anesthesia, a standardized ep-
ithelial incision was performed by using
an 8.0-mm well into which 20% alcohol
was instilled and left for 15 s. The alcohol
was removed, the eyes rinsed with a bal-
anced salt solution (BSS®; Alcon) and the
epithelium was removed and collected
manually with a disposable surgical
blade. LASEK was then performed with
the MEL 80 excimer laser systemTM (Carl
Zeiss Meditec, Jena, Germany), at a
wavelength of 193 nm, by use of a gauss-
ian beam with a 0.7-mm spot diameter
with a repetition rate of 250 Hz. The abla-
tion depth depended on the amount of
intended correction, and the ablation
zone diameter was 6.5 mm equally. After
ablation, balanced salt  solution chilled to
–4° was applied to the corneal surface for
30 s, followed by one drop of diclofenac
sodium 0.1% (Voltaren®; Norvatis, Basel,
Switzerland). After surgery the eyes were
covered with disposable soft contact
lenses  (PurevisionTM; Bausch & Lomb,
Rochester, NY, USA). Postoperatively, all
patients were treated with levofloxacin
1% eyedrops (Cravit®; Santen, Osaka,
Japan) four times a day until complete
reepithelization was established. After
LASEK, patients had a follow-up exami-
nation every 24 h until the corneal epithe-
lium completely closed, and corneal
wound-healing time was recorded. The
corneal epithelium was stained with fluo-
rescein and photographed at 3 d after
LASEK with a slit-lamp digital camera
(D1®; Nikon, Tokyo, Japan).
Western Blot Analysis
Tissues were harvested after LASEK
and solubilized for 30 min in ice-cold
lysis buffer containing 25 mmol/L
HEPES, pH 8.0, 150 mmol/L NaCl, 
1 mmol/L EDTA, 1 mmol/L Na3VO4, 
1 mmol/L NaF, 1% Triton X-100 and
protease inhibitors. Total protein in the
lysates was determined using a BCA
(bicinchoninic acid) protein assay kit
(Pierce; Rockford, IL, USA), according
to the manufacturer’s instructions. Cell
lysates containing equal amounts of
protein were resolved by SDS-PAGE
and transferred to nitrocellulose filters
(Protran; Schleicher & Schuell, Keene,
NH, USA). Blots were blocked with 5%
nonfat dried milk and 0.1% Tween 20,
treated with antibodies in blocking so-
lution overnight and then washed and
incubated with  horseradish peroxi-
dase–conjugated anti-IgGs (1:5000). The
immune complexes were visualized by
enhanced chemiluminescence.
Immunofluorescence Microscopy
Corneal epithelia from young (age 23
years) and elderly (age 65 years) patients
were permeabilized with 0.5% Triton
X-100 and fixed with 4% paraformalde-
hyde. Tissues were then incubated with
1% bovine serum albumin (BSA) in
20 mmol/L sodium phosphate (pH 7.4)
containing 150 mmol/L NaCl (phos-
phate-buffered saline [PBS]) to block
nonspecific labeling. For immunofluores-
cence used for human tissue, the primary
antipaxillin and anti–caveolin-1 poly-
clonal antibodies were diluted to 1:500 in
0.1% BSA in PBS. Tissues were washed
and incubated simultaneously with
Alexa 546-conjugated goat antirabbit sec-
ondary antibody (4 g/mL; Invitrogen,
Eugene, OR, USA) and Alexa 488-conju-
gated phalloidin (0.67 U/mL; Invitrogen)
in 0.1% BSA/PBS for 1 h. Coverslips
were mounted onto slides (Immu-mount;
Shandon Lipshaw, Pittsburgh, PA, USA),
and photographed (400×) on a DEF 280
microscope (Leica, Wetzlar, Germany).
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Figure 2. Caveolaelike structures in corneal epithelium from young, middle-aged and el-
derly patients. (A) Caveolaelike structures in corneal epithelia of one young (Y4, age 20
years), one middle-aged (M12, age 45 years), and one elderly (E20, age 70 years) patient
were visualized by using electron microscopic analysis. The arrow indicates caveolae
structures. Bar = 100 nm. (B) The number of caveolaelike vesicles in the corneal epithelium
of the three age groups were counted and plotted as a histogram with mean ± SD. Signif-
icant differences between young and middle-aged or elderly patients are indicated with
asterisks (**P < 0.01, and ***P < 0.001).
Electron Microscopy
Corneal epithelia from young, middle-
aged and elderly patients were fixed
with 3% glutaraldehyde in PBS (pH 7.4).
After being washed with 0.2 mol/L
sodium cacodylate buffer (pH 7.4), cell
pellets were treated with 1% osmium
tetroxide in cacodylate buffer for 1 h. Tis-
sues were then dehydrated in graded
ethanol through propylene oxide and
embedded in epoxy resin (Polyscience,
Warrington, PA, USA). Ultrathin sections
were cut and stained with uranyl acetate
and lead citrate. Sections were observed
by use of a transmission electron micro-
scope (H-600; Hitachi, Yokohama, Japan).
Adenoviral Caveolin-1 Vector
Preparation and Transfection
Infective recombinant adenovirus was
made by using the AdEasy system (22).
Recombinant adenovirus expressing
caveolin-1 (Adv/Cav-1) was produced by
inserting wild-type caveolin-1 cDNA into
a shuttle plasmid (pAdTRACK-CMV; In-
vitrogen, Carlsbad, CA, USA). After elec-
troporation, homologous recombination
was performed with the shuttle vector
and a large adenovirus-containing plas-
mid (pAdEasy-1) in Escherichia coli BJ518.
Recombinant viruses were selected with
kanamycin and subjected to restriction
endonuclease digestion. Infective aden-
ovirus virions were produced after trans-
fection of the linearized recombinant ade-
novirus plasmid in HEK293 cells. Virus
stocks were amplified in HEK293 cells on
15-cm plates and purified by using BD
Adeno-X purification kits (Clontech, Palo
Alto, CA, USA). A control vector
(Adv/GFP) carrying cDNA for modified
green fluorescence protein EGFP was also
prepared as described above.
Statistical Analysis
The Graph-Pad Prism (GraphPad, San
Diego, CA, USA) was used for statistical
analysis. One-way ANOVA was performed
to assess differences in preoperative spher-
ical equivalent refractive power among
the young, middle-aged and elderly
groups. Student t test was performed to
assess differences in wound-healing time
and relative caveolin-1 expression be-
tween young and elderly corneal epithelia.
Mean ± standard deviations (SD) of exper-
imental and control values in each group
are presented. P values less than 0.05 were
considered significant.
RESULTS
Aging Delays Corneal Wound Healing
after LASEK
There was no significant difference in
the preoperative refractive errors among
the young, middle-aged and elderly
groups (P = 0.48). After LASEK was per-
formed, corneal epithelial defects were
examined every 24 h until healing was
complete, and individual healing times
were recorded.
Wound-healing time was closely re-
lated to age (Table 1). The wound-
 healing time increased significantly (P <
0.001) with patient age, from 52.3 h for
the young group (age 20–29 years) to
70.8 h for the middle-aged group (age
40–49 years) and 99.7 h for the elderly
group (age >50 years) (Figure. 1).
Caveolin-1 and Paxillin Are Enriched
in Caveolae from Epithelia of Elderly
Patients
Electron microscopic studies of repre-
sentative corneal epithelia samples from
young (Y4, age 20 years), middle-aged
(M12, age 45 years) and elderly (E20, age
70 years) patients revealed the presence
of caveolaelike structures, which were
more abundant in middle-aged and el-
derly patients than in young patients
(Figure 2A, caveolae are indicated by ar-
rows). Quantitative analysis of caveolae
number in corneal epithelial cells
showed that elderly patients have five
times more caveolaelike structures than
young patients (P < 0.001), and middle-
aged patients have three times more (P <
0.01) (Figure 2B).
Increased caveolin-1 expression in el-
derly patients was also confirmed by
the results of immunofluorescence mi-
croscopic analysis (Figure 3). We exam-
ined paxillin and caveolin-1 expression
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Figure 3. Immunofluorescent staining of age-related protein, paxillin and caveolin-1 ex-
pression in corneal epithelia from young and elderly patients. Young (A, age 23 years)
and elderly (B, age 65 years) corneal epithelia were fixed and stained with antipaxillin
and anti–caveolin-1 antibodies. Nuclei were stained with 4’,6-diamidino-2-phenylindole
(DAPI). The paxillin-, caveolin-1– and DAPI-stained images were merged to reveal any
overlap. Immunofluorescence microscopy was performed as described in Materials and
Methods. Each experiment was performed three times with similar results.
and colocalization within caveolaelike
structures, based on previous observa-
tions that a significant proportion of
focal adhesion molecules, for example,
paxillin, were recruited to the caveolae
fraction in senescent human diploid fi-
broblast (HDF) cells (17). When young
and elderly corneal tissues were coim-
munostained with antipaxillin and
anti–caveolin-1 antibodies, paxillin colo-
calized with caveolin-1 in elderly
corneal epithelial cells (Figure 3B) but
not in young cells (Figure 3A). These
data suggest that the focal adhesion
protein and caveolin-1 are upregulated
in caveolae from elderly corneal tissues.
Caveolin-1 Status and Other Aging
Marker Proteins in Corneal Epithelia
Vary Among Individuals
We used Western blot analysis to ex-
amine the expression of caveolin-1 and
other markers of aging, such as p53 and
p21, in the corneal epithelia of five
young (Y1–Y5) and five elderly (E5–E9)
patients. Interestingly, not all elderly pa-
tients showed consistent increases in age-
related proteins compared with young
patients (Figure 4A). Among the five
young patients, two (Y4 and Y5) showed
upregulated caveolin-1 and one (Y5)
showed increased p21 expression.
Among the five elderly patients, two (E5
and E6) showed lower caveolin-1, p53
and p21 levels than other elderly pa-
tients. These data suggest that age-re-
lated protein expression does not corre-
late with chronological age but varies
among individuals.
To verify these data, we then used
Western blot analysis to examine cave-
olin-1, p53 and p21 expression in
corneal epithelia from an additional five
young and five elderly patients. The ex-
pression of these proteins in all 10
young (age 23 ± 3 years) and elderly pa-
tients (age 60 ± 5 years) was calculated
by using densitometric analysis of each
band and plotted as the relative density
of β-actin (Figure 4B). As expected,
caveolin-1, p53 and p21 levels were sig-
nificantly (*P < 0.05; ***P < 0.001) higher
in corneal epithelia from elderly (E in
Figure 4B) than young patients (Y in
Figure 4B).
Wound-Healing Time Correlates Well
with Caveolin-1 Status
We determined wound-healing status
by examining corneal epithelialization
status after fluorescein staining. Corneal
epithelial defects were stained with fluo-
rescein and then appeared green. The
wound-healing time was a measure of
the time to complete corneal epithelializa-
tion, indicated by the elimination of all
green staining. In this study, we also com-
pared corneal epithelialization 3 d after
LASEK in two young patients (Y3 and Y4
shown in Table 1), both aged 20 years,
with different caveolin-1 expression and
two elderly patients (E5 and E7 shown in
Table 1) with similar ages (58 and 60 years,
respectively) but different  caveolin-1 ex-
pression. Complete corneal epithelializa-
tion was observed 3 d after LASEK in both
young patients (Y3 and Y4 in Figure 5A),
but corneal defects (green-colored area)
remained in some elderly patients (E5 and
E7 in Figure 5A). Some degree of corneal
epithelial defect was observed in 13 of 20
elderly patients (65%).
Corneal wound-healing times differed
between two young patients (48 h for Y3
and 60 h for Y4) and two elderly patients
(84 h for E5 and 108 h for E7). Patients
with longer wound-healing times (Y4 and
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Figure 4. Individual differences in caveolin-1, p53 and p21 expression. (A) Corneal epithe-
lia from five young (Y1–Y5: age 20 years) and five elderly patients (E5–E9; age 58–60
years) were lysed in lysis buffer, and 30 μg protein from each lysate were analyzed by
Western blot by using antibodies specific against caveolin-1, p53 and p21. β-Actin was
also monitored as a control. (B) Caveolin-1, p53 and p21 expression in corneal epithelium
from 10 young (Y, black bars) and 10 elderly patients (E, white bars) were analyzed by
Western blot. The density of each protein was measured relative to β-actin. Bars represent
means ± SD. *P < 0.05 and ***P < 0.001 indicate significant differences in expression be-
tween young and elderly patients.
E7) showed upregulated caveolin-1 expres-
sion compared with the age-matched pa-
tients (Y3 and E5, respectively) (Figure 5B).
At the same time, p–extracellular signal-
regulated kinase (ERK) levels were upreg-
ulated in these patients with longer heal-
ing times (Figure 5B). These data indicate
a strong correlation of caveloin-1 status
with wound-healing time, suggesting that
caveolin-1 plays a role in modulating
wound healing in all age groups. Because
we observed that caveolin-1 status in the
corneal epithelium varies among individ-
uals, we examined the relationship be-
tween wound-healing time after LASEK
and caveolin-1 expression in a group of
patients (Figure 5C). We plotted the
wound-healing time versus the relative
caveolin-1 level for 30 patients to get a
correlation coefficient between determina-
tions (r). The r value of 0.9812 provides
strong evidence of a correlation between
these two parameters.
Suppressed EGF Signaling by
Caveolin-1 Overexpression in Human
Corneal Epithelial Cells
Hyporesponsiveness of senescent
 fibroblasts to EGF stimulation was
 suggested to be strongly related to upreg-
ulated caveolin-1. Caveolin-1 overexpres-
sion in young HDF cells may downregu-
late EGF signaling (8,16,17,23). To
confirm the role of caveolin-1 in corneal
epithelium, we overexpressed caveolin-1
in corneal epithelium cells. We trans-
fected corneal epithelial cells with an ade-
noviral vector that expressed both cave-
olin-1 and enhanced GFP (Adv/Cav-1)
or an adenoviral vector that expressed
enhanced GFP alone as a control
(Adv/GFP). Fluorescence microscopic
analysis revealed efficient viral vector
transfection (Figure 6A). Western blot
analysis showed the significant caveolin-
1 induction in Adv/Cav-1–infected cells
compared with Adv/GFP-infected cells
(Figure 6B). When EGF signaling was
compared between caveolin-1–induced
and control cells, the caveolin-1–overex-
pressing cells showed hyporesponsive-
ness to EGF. Mock transfection and
Adv/GFP control cells showed increased
ERK phosphorylation by EGF stimula-
tion, whereas EGF signaling was not acti-
vated in Adv/Cav-1–infected human
corneal epithelial cells (Figure 6C). There-
fore, our data suggest that caveolin-1
overexpression suppresses EGF mito-
genic signaling in corneal epithelial cells
as well as HDF cells (15).
DISCUSSION
Wound healing is a complex, tissue-
 dependent process. The initial action in-
volves removing damaged tissue. Next a
proliferative and migratory phase occurs,
in which cells invade the wound site to
initiate repair and replacement. To ma-
nipulate corneal wound healing, a
greater understanding of corneal physi-
ology at the subcellular level may be re-
quired. Changes associated with corneal
wound healing following LASEK could
occur in epithelium and stroma. Most
corneal wounds involve damage to the
epithelium, and epithelial healing time is
important to the final refractive outcome.
Immediately after LASEK, growth fac-
tors, cytokines, neuropeptides and
chemokines are released, initiating the
wound-healing cascade and undesirable
complications such as corneal haze (24).
After photorefractive keratectomy, the re-
lease of varying factors such as TGF-β,
EGF, PDGF, vascular endothelial growth
factor, hepatocyte growth factor and inter-
leukin-6 has been reported. These growth
factors have been further characterized by
a recurrent set of events in a wound-heal-
ing context: injury-induced growth factor
production and release, growth factor–in-
duced proliferative and migratory re-
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Figure 5. Correlation between corneal wound-healing time and caveolin-1 expression. (A)
Photographs showing corneal wound-healing status 3 d after LASEK. Corneas from young
(Y-1, age 20 years; Y-2, age 20 years) and elderly (E-5, age 58 years; E-7, age 60 years) pa-
tients were stained with fluorescein and photographed with a slit-lamp digital camera.
Complete corneal epithelizations were observed in young patients. Central epithelial de-
fects stained with fluorescein were still present in elderly patients. (B) Western blots of
corneal epithelia from young (Y3 and Y4) and elderly patients (E5 and E7). Corneal ep-
ithelia were lysed in lysis buffer and 30 μg protein from each lysate was analyzed by West-
ern blot by using antibodies against caveolin-1, p-ERK and ERK. The β-actin level was also
monitored as a control. (C) The relative levels of caveolin-1 from 10 young (black circle),
10 middle-aged (red triangle) and 10 elderly (green square) patients were analyzed by
using densitometry after Western blotting. The wound-healing times versus the relative
caveolin-1 level for 30 patients were plotted and analyzed to get a correlation coefficient
between determinations (r = 0.9812).
sponses and morphologic changes in tar-
get cells, additional growth factor regula-
tion through feedback loops and a specific
termination process (25). Endogenous
basic fibroblast growth factor (bFGF) lev-
els, a member of the FGF family (26), have
been shown to increase at injury sites (27).
Because of growth factor involvement
in wound-healing processes, there have
been many efforts to improve corneal
wound healing by modulating growth
factors. Several researchers have shown
that growth factors such as EGF, TGF-β,
bFGF, hepatocyte growth factor, PDGF,
interleukin-6 and keratinocyte growth
factor increase epithelial healing rates in
vitro, but their in vivo effects after topical
application are controversial (25). Some
groups have reported that topical EGF
application increased the wound-healing
rate in vivo, but others reported no bene-
fit. Moreover, a recent study showed that
eye drops containing bFGF significantly
accelerated epithelial healing after
LASEK by increasing corneal reepithe-
lialization in transgenic mice (28).
It is generally accepted that corneal
wound-healing time increases with age
(29,30) (Table 1). We also found that mean
wound-healing time after LASEK corre-
lated well with mean patient age. Patients
within similar age groups showed indi-
vidual variations in wound-healing time
after the LASEK procedure. By examining
markers of aging, such as caveolin-1, p53
and p21 in corneal epithelia from individ-
uals, we found that mean protein levels
were higher in elderly patients, with vari-
ations among individuals. These varia-
tions might reflect the individual aging
process, rather than chronological age.
In elderly patients who undergo
LASEK, reduced blood supply to the lens
or cornea could delay wound healing
(31,32). We postulated that age- dependent
inefficient responses to growth factors
might also delay corneal wound healing
in the elderly. We previously reported a
role of caveolin-1 in the senescent pheno-
type and its accumulation in aged animal
tissues, suggesting a suppressive role in
EGF responsiveness (16,23). Therefore, we
tested the role of caveolin-1 to suppress
EGF signaling in corneal epithelial cells.
In consequence, caveolin-1 transfection by
use of an adenoviral transfection system
showed hyporesponsiveness to EGF in
corneal epithelial cells, as previously
shown in HDF (16) and Chinese hamster
ovary cells (9). Our data confirm that
caveolin-1 is a mitogenic suppressive fac-
tor in the corneal epithelium. In this
study, we also observed that differences in
wound- healing time correlated well with
caveolin-1 levels of corneal epithelial cells
rather than chronological age, suggesting
that caveolin-1 in human corneal epithe-
lium might be a negative marker for in-
trinsic wound-healing  capacity.
Caveolin is well known to regulate
 signaling in caveolae. Anchorage-
 independent transformed fibroblast
growth disappeared after caveolin-1
overexpression. Suppression of caveolin-
1 stimulated transformation and acti-
vated mitogen-activated protein kinase
signaling (33). Overexpression of cave-
olin-1 also inhibited EGF-induced signal-
ing from EGFR to the Raf/MAP  kinase
ERK kinase (MEK)/Erk (Raf-MEK-ERK)
pathway, and the nucleus in Chinese
hamster ovary cells (9). In addition, cave-
olin-1 overexpression in mesangial cells
suppressed Raf-MEK-ERK activation and
cell proliferation induced by bFGF and
PDGF (34). In this study, we also found
that caveolin-1 overexpression in corneal
epithelial cells showed a reduction of
EGF-induced ERK phosphorylation. The
results of the present study suggest that
caveolin-1 inhibits the signaling induced
by growth factors such as EGF, bFGF and
PDGF in corneas, and might be responsi-
ble for delaying wound healing in el-
derly patients after LASEK.
In previous reports (35,36), it has been
shown that tear-film stability is mostly
influenced by age and sex, and dry-eye
changes are more marked in women than
in men. We used TBUT to assessed tear
function. Because normal eyes have a
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Figure 6. Adenovirus-mediated caveolin-1 upregulation in corneal epithelial cells. (A) An
adenoviral vector expressing both caveolin-1 and enhanced GFP (Adv/Cav-1) and an
adenoviral vector expressing enhanced GFP alone as a control (Adv/GFP) were used.
The efficiency of adenoviral infection was monitored by measuring fluorescence from GFP.
(B) Caveolin-1 production in Adv/Cav-1–infected human corneal epithelial cells was ana-
lyzed by Western blotting against caveolin-1 and compared with Adv/GFP-infected cells.
(C) Infected cells were stimulated with 100 μg/mL EGF for the indicated time (min). Total
cells were lysed in lysis buffer, and 30 μg protein from each lysate were analyzed by West-
ern blot against caveolin-1, EGFR, p-ERK and ERK. β-Actin was also monitored as a control.
TBUT of 15–45 s (21), we excluded cases
with a TBUT of less than 10 s to minimize
the influence of tear factors. Our cases
had TBUT within the normal range, and
no significant differences among groups
were found (data not shown). However,
we could not exclude the possibility that
age- and sex-dependent tear factors
played a role in wound healing directly
or indirectly via the regulation of cave-
olin expression. Further studies are
needed.
Taken together, these data indicate that
caveolin-1 status is a useful marker of
wound-healing efficiency after LASEK.
Therefore, we suggest that downregula-
tion of caveolin-1 might be a useful
method to facilitate wound healing in
vivo, especially for elderly patients un-
dergoing LASEK. This method may also
be used to facilitate wound healing in
other surgeries or traumas.
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